These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24862557)

  • 1. Adverse drug reactions in neonates and infants: a population-tailored approach is needed.
    Allegaert K; van den Anker JN
    Br J Clin Pharmacol; 2015 Oct; 80(4):788-95. PubMed ID: 24862557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Understanding and reducing the risk of adverse drug reactions in pediatric patients].
    Gotta V; van den Anker J; Pfister M
    Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database.
    Kaguelidou F; Beau-Salinas F; Jonville-Bera AP; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2016 Oct; 82(4):1058-68. PubMed ID: 27276109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An algorithm to detect adverse drug reactions in the neonatal intensive care unit.
    Du W; Lehr VT; Lieh-Lai M; Koo W; Ward RM; Rieder MJ; Van Den Anker JN; Reeves JH; Mathew M; Lulic-Botica M; Aranda JV
    J Clin Pharmacol; 2013 Jan; 53(1):87-95. PubMed ID: 23400748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.
    Kane-Gill SL; Forsberg EA; Verrico MM; Handler SM
    Drug Saf; 2012 Aug; 35(8):645-53. PubMed ID: 22720659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients.
    Vázquez-Alvarez AO; Brennan-Bourdon LM; Rincón-Sánchez AR; Islas-Carbajal MC; Huerta-Olvera SG
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):79. PubMed ID: 29216902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content.
    Herrera Comoglio R
    Br J Clin Pharmacol; 2020 Apr; 86(4):779-790. PubMed ID: 31770452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
    Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
    Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.
    Fabiano V; Mameli C; Zuccotti GV
    Expert Opin Drug Saf; 2012 Jan; 11(1):95-105. PubMed ID: 21548838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-Related Adverse Drug Events in Neonates: Recognition and Assessment.
    Allegaert K; van den Anker J
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S152-S160. PubMed ID: 34185907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse drug reactions in children].
    Jaffan L; Läer S
    Ther Umsch; 2011 Jan; 68(1):34-40. PubMed ID: 21184392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailored tools to improve pharmacotherapy in infants.
    Allegaert K
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1069-78. PubMed ID: 24961300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study.
    Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D
    Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions in neonates: a prospective study.
    Belén Rivas A; Arruza L; Pacheco E; Portoles A; Diz J; Vargas E
    Arch Dis Child; 2016 Apr; 101(4):371-6. PubMed ID: 26819267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in infants, children and adolescents exposed to antidepressants: a French pharmacovigilance study.
    Barthez S; Revet A; Chouchana L; Jonville-Bera AP; Pizzoglio V; Raynaud JP; Chebane L; Lapeyre-Mestre M; Montastruc F
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1591-1599. PubMed ID: 32588107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
    Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
    Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance for children's sake.
    Star K; Edwards IR
    Drug Saf; 2014 Feb; 37(2):91-8. PubMed ID: 24446277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the assessment of adverse drug reactions using the Naranjo Algorithm in daily practice: The Japan Adverse Drug Events Study.
    Murayama H; Sakuma M; Takahashi Y; Morimoto T
    Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.